Surveillance programs for early detection of hepatocellular carcinoma

Krzysztof Simon; Sylwia Serafińska; Monika Pazgan-Simon

doi:10.5114/wo.2012.30057

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2012
vol. 16

Send email

Copy url:

abstract:

Review paper

Surveillance programs for early detection of hepatocellular carcinoma

Krzysztof Simon

,

Sylwia Serafińska

,

Monika Pazgan-Simon

Wspolczesna Onkol 2012; 16 (4): 295–299
[Polish version: Wspolczesna Onkol 2012; 16 (4): 300–305]

DOI: https://doi.org/10.5114/wo.2012.30057

Online publish date: 2012/09/29

View full text Get citation

PlumX metrics:

Primary hepatocellular carcinoma (HCC) is the most commonly diagnosed primary malignancy of the liver. The number of new diagnosed cases of HCC seems to be on a rise worldwide. HCC is typically diagnosed in patients with underlying liver cirrhosis (> 90% cases) regardless of aetiology; over a five-year follow-up period HCC develops in 15–20% of patients with cirrhosis. Patients who are at a high risk of HCC development (i.e. individuals with liver cirrhosis, especially/or chronically infected with HBV or HCV) should undergo regular screening for HCC; the current screening standard comprises liver ultrasonography and determination ofα α-fetoprotein (AFP) concentration in blood serum at ca.

6 months’ intervals (now has been excluded from current diagnostic standards). Only such diagnostic methods are capable of detecting HCC early, and thus make it possible to treat the cancer effectively.

keywords:

Surveillance programs for early detection of hepatocellular carcinoma

Krzysztof Simon , Sylwia Serafińska , Monika Pazgan-Simon

hepatocellular carcinoma, liver cirrhosis, HBV and HCV infection, screening tests, α-fetoprotein

Krzysztof Simon

,

Sylwia Serafińska

,

Monika Pazgan-Simon